Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

The goal of this registry is to collect and store important medical and non-health information on children from 0 to 18 years of age affected by early- (up to 24 hours after birth) and late-onset (up to 90 days after birth) invasive Group B Streptococcus (iGBS) and their families. Data collected from families of children affected by perinatal iGBS will support further research to understand the short- and long-term impact of iGBS disease on affected children and its impact on their families. Participants will be invited to complete obstetric and pregnancy-related questionnaires as well as validated neurodevelopmental surveys at various timepoints throughout their participation in the registry.

NCT Number	NCT06896526
Lead Sponsor	Precia Group
Conditions	Invasive Group B Streptococcus Disease, Group B Streptococcus, Group B Streptococcal Infection, Group B Streptococcus (GBS) Disease, Group B Streptococcal Infection, Early-Onset, Group B Streptococcal Infection, Late-Onset
Enrollment	10,000 participants
Start Date	2025-04-01
Primary Completion	2035-03-31 (estimated)
Study Completion	2035-03-31 (estimated)
Updated on ClinicalTrials.gov	2025-03-26